Uriah Bekenstein

Uriah Bekenstein is the Founder and CEO at NucleoTech, with previous experience as a Biotechnology patent strategist at FuturaGene Ltd. Uriah also worked as a PhD student at Hebrew University focusing on RNA biology in neurodegeneration. Prior to that, Uriah was a Laboratory Instructor at Azrieli College of Engineering Jerusalem and served as a Liaison Officer in the Israel Defense Forces.